None listed
Conditions
Brief summary
This is a prospective observational study of the diagnostic utility of the "Triage" multi-marker point of care blood testing device to measure the levels of the cardiac markers Troponin I, Creatine Kinase MB and myoglobin: - in people presenting to the Emergency Deprtment with chest pain of probable caridac origin. Blood samples will be taken and tested on arrival and again at 2 hours. Participants will undergo risk evaluation by a means of a set series of questions. Participants will recieve a phone call at 45 days, 6 months and 1 year post discharge to record any major adverse cardiac event (MACE) they may have experienced.
Interventions
ASPECT: The Triage multi-marker panel consists of measurements of Troponin I, Creatine Kinase MB (CKMB) and myoglobin levels using a point of care testing device for blood samples taken from people who present with probable ischaemic chest pain to the Emergency Department. A sample is tested on arrival and again 2 hours later.
Sponsors
Inverness Medical Innovations
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Adults presenting to the trial hospital Emergency Department with chest pain of possible cardiac origin
Exclusion criteria
Age < 18 years. Non-resident in country of recruitment. Patients for whom follow-up will not be possible either due to lack of onward contact address or because they will be overseas. Unable or unwilling to consent
Outcome results
None listed